Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 30 May 2006
Vol. 2006, Issue 337, p. eg8
[DOI: 10.1126/stke.3372006eg8]

EDITORIAL GUIDES

Focus Issue: Turning the Corner in Cancer Therapy?

Elizabeth M. Adler1*, Nancy R. Gough2, and L. Bryan Ray3

1Associate Editor of Science's STKE, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.
2Managing Editor of Science's STKE, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.
3Editor of Science's STKE and Senior Editor of Science, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.

Summary: This week’s issues of Science and Science’s STKE are devoted to cancer research and to exploring how recent discoveries may impact our ability to diagnose and treat cancer. Science's STKE focuses on mechanisms by which growth factor–mediated stimulation of hypoxia-inducible factor signaling contributes to cancer progression and research that suggests a role as a tumor suppressor for a splicing variant of the c-H-ras oncogene.

*Corresponding author. E-mail, eadler{at}aaas.org

Citation: E. M. Adler, N. R. Gough, L. B. Ray, Focus Issue: Turning the Corner in Cancer Therapy? Sci. STKE 2006, eg8 (2006).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882